Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A case of pancreatic arteriovenous malformation caused acute pancreatitis.
Nagata K, Tajiri K, Muraishi N, Kobayashi S, Sibuya K, Yoshioka I, Fujii T, Tanaka S, Imura J, Yasuda I. Nagata K, et al. Among authors: fujii t. Clin J Gastroenterol. 2021 Feb;14(1):364-369. doi: 10.1007/s12328-020-01231-3. Epub 2020 Sep 21. Clin J Gastroenterol. 2021. PMID: 32955705
Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective Analysis.
Ando T, Ueda A, Ogawa K, Motoo I, Kajiura S, Nakajima T, Hirano K, Okumura T, Tsukada K, Hara T, Suzuki N, Nakada N, Horikawa N, Fujii T, Yasuda I. Ando T, et al. Among authors: fujii t. In Vivo. 2021 Jan-Feb;35(1):475-482. doi: 10.21873/invivo.12281. In Vivo. 2021. PMID: 33402499 Free PMC article.
Factors, Including Clinical Trial Eligibility, Associated with Induction of Third-Line Treatment for Advanced Gastric Cancer.
Ando T, Hosokawa A, Sakumura M, Motoo I, Kajiura S, Hirano K, Miwa T, Yokota T, Nakada N, Ueda Y, Ueda A, Tsukada K, Ogawa K, Nakaya A, Teramoto A, Nanjo S, Mihara H, Fujinami H, Fujii T, Yasuda I. Ando T, et al. Among authors: fujii t. Oncology. 2023;101(1):59-68. doi: 10.1159/000526577. Epub 2022 Sep 14. Oncology. 2023. PMID: 36103845
Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor.
Oya H, Kanda M, Sugimoto H, Shimizu D, Takami H, Hibino S, Hashimoto R, Okamura Y, Yamada S, Fujii T, Nakayama G, Koike M, Nomoto S, Fujiwara M, Kodera Y. Oya H, et al. Among authors: fujii t. J Gastroenterol. 2015 May;50(5):590-600. doi: 10.1007/s00535-014-0993-4. Epub 2014 Aug 31. J Gastroenterol. 2015. PMID: 25173447
6,524 results